IP Library Granted Patent US 9,884,889
Granted Patent B2
US 9,884,889 · App. 14/844,468 · Granted Feb 6, 2018

Multisignal labeling reagents and processes and uses therefor

Inventors: Jack Coleman (East Northport, NY); Elazar Rabbani (New York, NY); Jannis Stavrianopoulos (Bay Shore, NY); Praveen Pande (Holbrook, NY)
Assignee: Enzo Life Sciences, Inc.
C07H21/00C07D219/08C07D405/14C07D491/22C07H21/04C09B11/00C09B11/08C09B11/24C09B57/02C12Q1/68C12Q1/6818G01N33/533G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,889
App. No.
14/844,468
Granted
Feb 6, 2018
Kind
B2
Abstract

Provided are compounds comprising two DNA supramolecular binding molecules covalently joined by a linker group. Also provided are multisignal labeling reagents comprising (i) an oligomer of nucleotides or nucleotide analogs; (ii) a DNA supramolecular binding molecule noncovalently bound to the oligomer; and (iii) a first reactive group or a first partner of a first binding pair covalently bound to the oligomer. Additionally provided are methods of producing multisignal labeling reagents.

Claims (20)

1. A multisignal labeling reagent comprising:

(i) an oligomer of nucleotides or nucleotide analogs;

(ii) a plurality of DNA supramolecular binding molecules noncovalently bound to the oligomer,

wherein said DNA supramolecular binding molecules comprise a detectable label attached thereto that is not a DNA supramolecular binding molecule, and

wherein said DNA supramolecular binding molecules are selected from minor groove binders and major groove binders; and

(iii) a first reactive group covalently bound to the oligomer, or

a first partner of a first binding pair covalently bound to the oligomer.

2. The multisignal labeling reagent of claim 1 , wherein the DNA supramolecular binding molecule is fluorescent.

3. The multisignal labeling reagent of claim 1 , wherein the detectable label is non-radioactive.

4. The multisignal labeling reagent of claim 3 , wherein the non-radioactive detectable label is a fluorophore.

5. The multisignal labeling reagent of claim 3 , wherein the non-radioactive detectable label is a chemiluminescent or phosphorescent moiety.

6. The multisignal labeling reagent of claim 1 , wherein the DNA supramolecular binding molecules comprise DNA supramolecular binding molecules which are minor groove binders.

7. The multisignal labeling reagent of claim 6 , wherein the minor groove binders comprise a minor groove binder selected from the group consisting of a diacrylamidine and a bis-benzimidazole.

8. The multisignal labeling reagent of claim 6 , wherein the minor groove binders comprise a minor groove binder selected from the group consisting of DAPI, berenil, pentamidine, distamycin A, and Hoechst 33258.

9. The multisignal labeling reagent of claim 1 , wherein the DNA supramolecular binding molecules comprise DNA supramolecular binding molecules which are major groove binders.

10. The multisignal labeling reagent of claim 9 , wherein the major groove binders comprise a major groove binder selected from the group consisting of a zinc finger, a leucine zipper, and a helix-turn-helix motif.

11. The multisignal labeling reagent of claim 1 , comprising the first partner of the first binding pair covalently bound to the oligomer.

12. The multisignal labeling reagent of claim 11 , wherein the first binding pair is a ligand/receptor, a hormone/receptor, biotin/avidin, biotin/streptavidin or an antigen/antibody binding pair.

13. The multisignal labeling reagent of claim 11 , wherein the first partner of the first binding pair is streptavidin.

14. The multisignal labeling reagent of claim 1 , comprising the first reactive group covalently bound to the oligomer.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2015
From: COLEMAN, JACK; RABBANI, ELAZAR; STAVRIANOPOULOS, JANNIS; PANDE, PRAVEEN
To: ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM
Reel/Frame 036766/0387 →
Continuity (4)
Division 13065101 · Mar 14, 2011
Continuation In Part 12399393 · Mar 6, 2009
Division 10407818 · Apr 3, 2003
Related Publication 20160025716A1 · Jan 28, 2016